Vorce SP, Holler JM, Cawrse BM, Magluilo J. Dimethylamylamine: A drug causing positive immunoassay results for amphetamines. J Anal Toxicol 2011;35:183-7. View abstract.

The World Anti-Doping Code. The 2010 Prohibited List International Standard. Word Anti-Doping Agency, September 19, 2009. Available at: http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited-list/WADA_Prohibited_List_2010_EN.pdf

Adverse Event Report. Jack3d. Natural MedWatch, May 28, 2011.

Daniells S. AHPA takes '1st stand' on labeling of DMAA-geranium oil. Nutraingredients-usa.com, August 9, 2011. Available at: http://www.nutraingredients-usa.com/Industry/AHPA-takes-1st-stand-on-labeling-of-DMAA-geranium-oil. (Accessed 12 August 2011).

Starling S. Synthetic geranium substance raises ephedra-like red flags. Nutraingredients-use.com, May 11, 2010. Available at: http://www.nutraingredients-usa.com/Industry/Synthetic-geranium-substance-raises-ephedra-like-red-flags. (Accessed 12 August 2011).

Gee P, Jackson S, Easton J. Another bitter pill: a case of toxicity from DMAA party pills. N Z Med J 2010;123:124-7. View abstract.

AHPA clarifies its position on the science linking DMAA to geranium oil; new research on DMAA in geranium reported. AHPA News Room, August 11, 2011. Available at: http://www.ahpa.org/Default.aspx?tabid=69&aId=709. (Accessed 4 January 2012).

McCarthy C, Farney TM, Canale RE, et al. A finished dietary supplement stimulates lipolysis and metabolic rate in young men and women. Nutr Metab Insights 2012;5:23-31.

McCarthy C, Canale RE, Alleman RJ, et al. Biochemical and anthropometric effects of a weight loss dietary supplement in health men and women. Nutr Metab Insights 2012;5:13-22.

Farney TM, McCarthy C, Canale RE, et al. Hemodynamic and hematologic profile of health adults ingesting dietary supplements containing 1,3-dimethylamylamine and caffeine. Nutr Metab Insights 2012;5:1-12.

UPDATE to ALFOODACT 034-2011 and ALFOODACT 036-2011, and 041-2011 Dimethylamylamine (DMAA) Is Placed On Medical Hold Due To Possible Serious Adverse Health Effects. DLA Troop Support, December 30, 2011. Available at: http://www.dscp.dla.mil/subs/fso/alfood/2011/alf04411.pdf. (Accessed 4 January 2012).

FDA challenges marketing of DMAA products for lack of safety evidence. US Food and Drug Administration, April 27, 2012. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm302133.htm

Classification of 1,3-dimethylamylamine (DMAA). Health Canada, July 7, 2011.

DMAA Banned from 9 April 2012. Ministry of Health, New Zealand, March 23, 2012. Available at: http://www.health.govt.nz/news-media/news-items/dmaa-banned-9-april-2012

Young C, Oladipo O, Frasier S, et al. Hemorrhagic stroke in young healthy male following use of sports supplement Jack3d. Mil Med 2012;177(12):1450-4. View abstract.

Smith TB, Staub BA, Natarajan GM, et al. Acute myocardial infarction associated with dietary supplements containing 1,3-dimethylamylamine and Citrus aurantium. Tex Heart Inst J 2014;41(1):70-2. View abstract.

Liu Y, Santillo MF. Cytochrome P450 2D6 and 3A4 enzyme inhibition by amine stimulants in dietary supplements. Drug Test Anal. 2016;8(3-4):307-10. View abstract.

Archer JR, Dargan PI, Lostia AM, van der Walt J, Henderson K, Drake N, Sharma S, Wood DM, Walker CJ, Kicman AT. Running an unknown risk: a marathon death associated with the use of 1,3-dimethylamylamine (DMAA). Drug Test Anal. 2015 May;7(5):433-8. View abstract.

Armstrong M. Atrial Fibrillation with Rapid Ventricular Response following use of Dietary Supplement Containing 1,3 Dimethylamylamine and Caffeine. J Spec Oper Med. 2012 Winter;12(4):1-4. View abstract.

Austin KG, Travis J, Pace G, Lieberman HR. Analysis of 1,3 dimethylamylamine concentrations in Geraniaceae, geranium oil and dietary supplements. Drug Test Anal. 2014 Jul-Aug;6(7-8):797-804. View abstract.

Bloomer RJ, Farney TM, Harvey IC, Alleman RJ. Safety profile of caffeine and 1,3-dimethylamylamine supplementation in healthy men. Hum Exp Toxicol. 2013 Nov;32(11):1126-36. View abstract.

Brown JA, Buckley NA. Toxicity from bodybuilding supplements and recreational use of products containing 1,3-dimethylamylamine. Med J Aust. 2013 May 6;198(8):414-5. View abstract.

Di Lorenzo C, Moro E, Dos Santos A, Uberti F, Restani P. Could 1,3 dimethylamylamine (DMAA) in food supplements have a natural origin? Drug Test Anal. 2013 Feb;5(2):116-21. View abstract.

Dolan SB, Gatch MB. Abuse liability of the dietary supplement dimethylamylamine. Drug Alcohol Depend. 2015 Jan 1;146:97-102. View abstract.

Dunn M. Have prohibition policies made the wrong decision? A critical review of studies investigating the effects of DMAA. Int J Drug Policy. 2017 Feb;40:26-34. View abstract.

Eliason MJ, Eichner A, Cancio A, Bestervelt L, Adams BD, Deuster PA. Case reports: Death of active duty soldiers following ingestion of dietary supplements containing 1,3-dimethylamylamine (DMAA). Mil Med. 2012 Dec;177(12):1455-9. View abstract.

Fleming HL, Ranaivo PL, Simone PS. Analysis and Confirmation of 1,3-DMAA and 1,4-DMAA in Geranium Plants Using High Performance Liquid Chromatography with Tandem Mass Spectrometry at ng/g Concentrations. Anal Chem Insights. 2012;7:59-78. View abstract.

Forrester M. Exposures to 1,3-dimethylamylamine-containing products reported to Texas poison centers. Hum Exp Toxicol. 2013 Jan;32(1):18-23. View abstract.

Gauthier TD. Evidence for the Presence of 1,3-Dimethylamylamine (1,3-DMAA) in Geranium Plant Materials. Anal Chem Insights. 2013 Jun 6;8:29-40. View abstract.

Palmer PG Jr. Deadly dimethylamylamine: "health" supplements are killing consumers while current regulations impede FDA action. J Leg Med. 2014;35(2):311-36. View abstract.

Rodricks JV, Lumpkin MH, Schilling BK. Pharmacokinetic data distinguish abusive versus dietary supplement uses of 1,3-dimethylamylamine. Ann Emerg Med. 2013 Jun;61(6):718-9. View abstract.

Schilling BK, Hammond KG, Bloomer RJ, Presley CS, Yates CR. Physiological and pharmacokinetic effects of oral 1,3-dimethylamylamine administration in men. BMC Pharmacol Toxicol. 2013 Oct 4;14:52. View abstract.

Van Hout MC, Hearne E. "Plant or poison": A netnographic study of recreational use of 1,3-dimethylamylamine (DMAA). Int J Drug Policy. 2015 Dec;26(12):1279-81. View abstract.

Whitehead PN, Schilling BK, Farney TM, Bloomer RJ. Impact of a dietary supplement containing 1,3-dimethylamylamine on blood pressure and bloodborne markers of health: a 10-week intervention study. Nutr Metab Insights. 2012 Feb 2;5:33-9. View abstract.

REPORT OF THE DEPARTMENT OF DEFENSE 1,3 DIMETHYLAMYLAMINE (DMAA) SAFETY REVIEW PANEL. June 3, 2013. Available at: http://hprc-online.org/dietary-supplements/opss/operation-supplement-safety-OPSS/tools-for-providers/files/ReportoftheDoDDMAASafetyReviewPanel2013.pdf

Rickli A, Hoener MC, Liechti ME. Pharmacological profiles of compounds in preworkout supplements ("boosters"). Eur J Pharmacol 2019;859:172515. View abstract.